Induction of ovulation with clomiphene citrate in combination with metoclopramide in patients with amenorrhea of hypothalamic origin

References

• Rowe T C, Pridy S M. The action of clomiphene in stress-induced amenorrhea. Am J Obstet Gynecol 1984; 148: 613–16
   PubMed Web of Science ®Google Scholar
• Pepperell R J. A rational approach to ovulation induction. Fertil Steril 1983; 40: 1–14
   PubMed Web of Science ®Google Scholar
• Yen SSC. Chronic anovulation due to CNS-hypothalamic-pituitary dysfunction. Reproductive Endocrinology 2nd edn., SCC Yen, RB Jaffe. WB Saunders, Philadelphia 1986; 500–45
   Google Scholar
• Tolis G, Diamanti E. Distress amenorrhea. Ann NY Acad Sci 1995; 771: 660–4
   PubMed Web of Science ®Google Scholar
• Quigley M E, Sheehan K L, Yen SSC. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea. J Clin Endocrinol Metab 1980; 50: 949–54
   PubMed Web of Science ®Google Scholar
• Genazzani A D, Gastaldi M, Petraglia F, et al. Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. Hum Reprod 1995; 10: 2868–71
   PubMed Web of Science ®Google Scholar
• Djursing H, Hagen C, Andersen A N, et al. Prolonged dopamine receptor blockade in normoprolactinemic amenorrhea: a double-blind placebo study. Fertil Steril 1986; 46: 840–5
   PubMed Web of Science ®Google Scholar
• Andersen A N, Hagen C, Lange P, et al. Dopaminergic regulation of gonadotropin levels and pulsatility in normal women. Fertil Steril 1987; 47: 391–7
   PubMed Web of Science ®Google Scholar
• Quigley M E, Judd S J, Gilliland G B, et al. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation. J Clin Endocrinol Metab 1979; 48: 718–20
   PubMed Web of Science ®Google Scholar
• Ferriani R A, Silva de Sá M F, Moura M D, et al. Dopamine may not be involved in the pathogenesis of polycystic ovary syndrome. Gynecol Endocrinol 1989; 3: 317–27
   PubMed Web of Science ®Google Scholar
• Seki K, Nagata I. Effects of a dopamine antagonist (metoclopramide) on the release of LH, FSH, TSH and PRL in normal women throughout the menstrual cycle. Acta Endocrinol 1990; 122: 211–16
   PubMedGoogle Scholar
• Seki K, Uesato T, Kato K. Effects of a dopamine antagonist (metoclopramide) on the release of the adenohypophyseal hormones in amenorrhoeic patients with and without hyperprolactinemia. Acta Endocrinol 1982; 101: 166–70
   PubMedGoogle Scholar
• Hagen C, Petersen K, Djursing H, et al. Evidence of altered dopaminergic modulation of PRL, LH and TSH secretion in patients with normoprolactinemic amenorrhoea. Acta Endocrinol 1984; 106: 8–14
   PubMedGoogle Scholar
• Mendes M C, Ferriani R A, Fernandes Costa LOB, et al. Cortisol levels alter the response to metoclopramide in patients with hypothalamic amenorrhea. Gynecol Endocrinol 1995; 9: 9–14
   PubMed Web of Science ®Google Scholar
• Larsen S. Responses of luteinizing hormone, follicle-stimulating hormone, and prolactin to prolonged administration of a dopamine agonist in normal women and women with low-weight amenorrhea. Fertil Steril 1981; 35: 642–6
   PubMed Web of Science ®Google Scholar
• Kauppila A, Leinonen P, Vihko R, et al. Metoclopramide-induced hyperprolactinemia impairs ovarian follicle maturation and corpus luteum function in women. J Clin Endocrinol Metab 1982; 54: 955–60
   PubMed Web of Science ®Google Scholar
• Hagen C, Andersen A N, Djursing H. Evidence of altered dopaminergic modulation of PRL, LH, FSH, GH and TSH secretion during chronic partial dopamine receptor blockade in normal women. Acta Endocrinol 1984; 106: 1–7
   PubMedGoogle Scholar
• Ferriani R A, Silva de Sá M F, Lima Filho E C. A comparative study of longitudinal and cross-sectional changes in plasma levels of prolactin and estriol during normal pregnancy. Braz J Med Biol Res 1986; 19: 183–8
   PubMed Web of Science ®Google Scholar
• Plosker S M, Marshall L A, Martin M C, et al. Opioid, catecholamine, and steroid interaction in prolactin and gonadotropin regulation. Obstet Gynecol Survey 1990; 45: 441–53
   PubMedGoogle Scholar
• Gudelsky G A, Nansel D D, Porter J C. Role of estrogen in the dopaminergic control of prolactin secretion. Endocrinology 1981; 108: 440–4
   PubMed Web of Science ®Google Scholar
• Judd S J, Rigg L A, Yen SSC. The effects of ovariectomy and estrogen treatment on the dopamine inhibition of gonadotropin and prolactin release. J Clin Endocrinol Metab 1979; 49: 182–4
   PubMed Web of Science ®Google Scholar
• Golden N H, Shenker I R. Amenorrhea in anorexia nervosa. Neuroendocrine control of hypothalamic dysfunction. Int J Eating Disorders 1994; 16: 53–60
   PubMed Web of Science ®Google Scholar
• Corenblum B, Taylor P J. Utilization of the biochemical response to clomiphene citrate for the selection of women with hypothalamic amenorrhea who require further investigation. Fertil Steril 1987; 48: 766–9
   PubMed Web of Science ®Google Scholar
• Adashi E Y. Clomiphene citrate: mechanism(s) and site(s) of action – an action hypothesis revisited. Fertil Steril 1984; 42: 331–44
   PubMed Web of Science ®Google Scholar
• Moura M D, Ferriani R A, Silva de Sá M F. Effects of clomiphene citrate on pituitary luteinizing hormone and follicle stimulating hormone release in women before and after treatment with ethinyl estradiol. Fertil Steril 1992; 58: 504–7
   PubMed Web of Science ®Google Scholar
• Miyake A, Tasaka K, Sakumoto T, et al. Clomiphene citrate induces luteinizing hormone release through hypothalamic luteinizing hormone-releasing hormone in vitro. Acta Endocrinol 1983; 103: 289–92
   PubMedGoogle Scholar
• Garcia-Flores R F, Vázquez-Méndez J. Progressive dosages of clomiphene in hypothalamic anovulation. Fertil Steril 1984; 42: 543–7
   PubMed Web of Science ®Google Scholar